Edward Oliver Gillespie

Edward Oliver Gillespie, then-CEO of AGIG, bought 11,000 shares at $1.18 on 2026-06-12; stock now at $1.14, down 78.5% from 52-week high.

Edward Oliver Gillespie, who was CEO at the time, purchased 11,000 shares at $1.18, expanding his holdings to 202,248 shares (+5.8% increase). The stock is currently trading at $1.14, representing a -78.5% decline from the 52-week high of $5.31. His prior trades at AGIG show a mixed pattern: of 5 prior purchases, only one had a measurable 90-day outcome (a -21.7% return from the 2025-12-23 buy), indicating poor timing on that tracked transaction. The company's fundamentals reflect significant operational stress, with annual revenue declining 26.7% year-over-year, a latest-quarter revenue of $133.0K, and a full-year net loss of $-5.2M. The timing of this accumulation during a period of sustained stock weakness (-36.0% over 90 days, despite +3.6% over 30 days) against deteriorating financial metrics warrants investor scrutiny into the rationale and circumstances of the purchase.

Then-CEO Gillespie Oliver buys 14,990 shares of AGIG at $1.15; stock down 78.5% from 52-week high amid unprofitable operations.

Gillespie Edward Oliver, who was CEO at the time, purchased 14,990 shares of ABUNDIA GLOBAL IMPACT GROUP, INC. at $1.15 on 2026-05-18, increasing his holdings by 8.5% to 191.2K shares. The purchase occurs while the stock is trading at $1.14, representing -78.5% from its 52-week high of $5.31 and follows a 90-day decline of -74.7%. Fundamentally, the company reported a net loss of $-5.2M in its most recent fiscal year, with annual revenue down 26.7%, though revenue in the latest quarter was $133.0K. His prior three purchases at AGIG showed pattern inconsistency: 30-day returns ranged from +50.8% to +96.4%, but all three turned negative by the 90-day mark, with a worst case of -23.0%. A cluster of 2 other insiders also bought within 14 days. The absence of well-timed 90-day outcomes across his prior AGIG transactions, combined with the company's loss-making state and sharp revenue decline, creates a mixed signal: the timing of entry into a deeply depressed stock occurs alongside a track record of reversals at this ticker and ongoing operational deterioration.

CEO Gillespie Edward Oliver buys 31.2K shares for $37.0K; stock down -61.1% in 90 days amid -26.7% revenue decline.

Gillespie Edward Oliver, CEO, purchased 31,220 shares totaling $36,981.70 across three transactions, bringing post-transaction holdings to 176,258 shares. This buy occurs while AGIG's stock trades at $1.17, approximately 78% below the 52-week high of $5.31, and the company reported quarterly revenue of $132,965.00 against a net loss of $-5,229,104.00. The company faces structural headwinds with annual revenue declining -26.7% year-over-year. His prior buy track record shows conflicting outcomes across timeframes: at the 30-day mark, an average return of +72.6%, yet at the 90-day mark, an average return of -16.9% with a 0.00% win rate, indicating near-term recoveries that fail to sustain over longer horizons.

CEO Oliver buys 12,500 shares ($23.9K) at $1.92 while AGIG faces -29.4% revenue decline and $-7.0M net loss

CEO Edward Oliver Oliver purchased 12,500 shares on 2025-12-23, increasing his holdings by 32.5% to 50,961 shares post-transaction. The purchase occurred at $1.92 per share, just 12 trading days after the company's listing, during a period when AGIG's fundamentals show acute deterioration: annual revenue contracted -29.4% against the prior year, with latest quarterly revenue at $200,000.00 against a full-year net loss of $-7,031,914.00. The CEO's equity commitment signals material risk absorption—Oliver is doubling down on a highly unprofitable operation in its early public-market phase, at a moment when operational headwinds are evident in the consolidated results.

CEO Gillespie bought 38,461 shares in AGIG across 2 transactions for $71,260.65 (avg $1.85) on 12/19 and 12/22

CEO Edward Oliver Gillespie made two consecutive purchases of AGIG shares on December 19 and December 22, acquiring 38,461 shares totaling $71,260.65 at a blended average price of $1.85. The company is in early-stage public trading (12 trading days post-listing), recently unprofitable with full-year net income of $-7,031,914.00, and faces significant headwinds with annual revenue growth of -29.4% and latest quarterly revenue of only $200,000.00. The current stock price of $2.03 reflects a modest premium to the average transaction price, yet the absence of meaningful 52-week history or a meaningful operating profit profile makes this a speculative position. An investor should monitor whether this acquisition reflects genuine business confidence or opportunistic accumulation during a volatile IPO phase in a loss-making entity.